Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,468,243
-
Total 13F shares
-
63,829,194
-
Share change
-
-3,915,618
-
Total reported value
-
$988,058,899
-
Put/Call ratio
-
70%
-
Price per share
-
$15.48
-
Number of holders
-
165
-
Value change
-
-$54,468,075
-
Number of buys
-
82
-
Number of sells
-
64
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q4 2020
As of 31 Dec 2020,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,829,194 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, Palo Alto Investors LP, VANGUARD GROUP INC, FRONTIER CAPITAL MANAGEMENT CO LLC, ALKEON CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Delphi Management Partners VIII, L.L.C., and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
165
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.